Evidence-Based Biotech Intelligence
BioSniper aggregates data from 7 authoritative public sources and applies multi-agent AI cross-verification to deliver research you can trust.
Our Mission
Biotech investment decisions demand reliable data, not guesswork. BioSniper was built to bridge the gap between raw public data and actionable intelligence — giving investors, analysts, and researchers a single platform to track 1,000+ companies across SEC filings, FDA actions, clinical trials, scientific literature, patents, news, and market data.
7 Authoritative Data Sources
SEC EDGAR
10-K, 10-Q, 8-K, S-1 filings & insider transactions
FDA
PDUFA dates, approvals, CRLs & Advisory Committee meetings
ClinicalTrials.gov
Trial registrations, status changes & readouts
PubMed
Peer-reviewed scientific literature
Patents
USPTO & Google Patents via BigQuery
News
Real-time biotech & pharma news aggregation
Market Data
Stock quotes, ETFs & market indicators
Zero-Hallucination AI
Our multi-agent architecture ensures every AI conclusion is grounded in verifiable evidence. Multiple specialized agents — financial, clinical, regulatory, patent, and market — independently analyze a company and cross-verify each other's findings.
- Every claim must cite original source data
- Unverifiable claims are marked UNKNOWN — never guessed
- Zero-hallucination policy enforced at system level, cannot be overridden
Start Making Data-Driven Decisions
Join researchers and investors who rely on BioSniper for evidence-based biotech intelligence.